The size of the Prosthetic Heart Valves Market in the Asia Pacific is valued at USD 0.99 billion in 2022. It is estimated to be growing at a CAGR of 14.21% to reach USD 1.93 billion by 2027. This market is strongly driven by the growing medical tourism industry, increasing heart repair and transplantation surgeries, reimbursement scenarios, and technological advancements.
Additionally, factors such as unhealthy lifestyle, lack of physical activities that may cause different cardiac diseases, and pathological disorders are likely to accelerate the market growth in the Asia Pacific region during the forecast period. The growing population in this region, developing healthcare infrastructure, growing awareness for initial diagnosis, and treatment availability towards the heart valve disorders are further expected to propel the market growth during the forecast.
High costs of the heart valves and the associated treatments and development are majorly hampering the market growth. Strict regulations for the devices' approval, the shortage of experienced and knowledgeable professionals, and inadequate reimbursement issues are some of the key factors restraining market growth.
This research report on the Asia Pacific Prosthetic Heart Valves Market segmented and sub-segmented into the following categories:
Regionally, Asia-Pacific is expected to grow rapidly in the coming years, as is evident from the high CAGR value for the region. In addition to being the fastest-growing market, the region also has the third-highest market share only behind the likes in North America and Europe. The region's high growth rate can be attributed to the developing economies of China and India and the scope for research in the area. It is also much more comfortable for new companies to enter the market in the region.
The Chinese market is leading the Asia pacific prosthetic valves market during the forecast period due to the rising discretionary expenses, increasing the high incidence rate of heart valve diseases.
Noteworthy Companies leading the Asia pacific Prosthetic Heart Valves Market are Corvia Medical, CardioKinetix, Biomerics LLC, Lepu Medical Technology, XELTIS BV, Comed BV, HLT, Meril Life Sciences, SYMETIS SA, and Transcatheter Technologies GmbH.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type
5.1.1 Introduction
5.1.2 Mechanical Heart Valve
5.1.3 Tissue Heart Valve
5.1.4 Transcatheter Heart Valve
5.1.5 Y-o-Y Growth Analysis, By Type
5.1.6 Market Attractiveness Analysis, By Type
5.1.7 Market Share Analysis, By Type
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Type
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Type
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Type
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Corvia Medical
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 CardioKinetix
8.3 Biomerics LLC
8.4 Lepu Medical Technology
8.5 XELTIS BV
8.6 Comed BV
8.7 Meril Life Sciences
8.8 SYSMETIS SA
8.9 HLT
8.10 Transcatheter Technologies GmbH
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.
